Sociedad Americana de Hirudoterapia

Dirección Nacional de Vigilancia Sanitaria — Ministerio de Salud Pública y Bienestar Social

DINAVISA · Paraguay · latin america

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Paraguay's National Directorate of Health Surveillance (Ministry of Public Health) — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
latin america
Country
Paraguay
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Paraguayan Ley 1119/97 De productos para la salud y otros
  • Paraguayan national medical device regulatory framework
  • MERCOSUR harmonised pharmaceutical and medical device frameworks where applicable

Prescriber Requirements

  • Paraguayan Círculo Paraguayo de Médicos–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

DINAVISA registration as applicable; Spanish-language labelling required by national law (with Guaraní supplementary information where relevant). Standard cold-chain conditions.

Import/Export Rules

DINAVISA and Servicio Nacional de Calidad y Salud Animal (SENACSA) clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Instituto de Previsión Social (IPS) coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. MERCOSUR regulatory frameworks rely on a mixture of national and regional harmonisation; whether this captures live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.